Like much else in US patent litigation, the cost of IPRs skews the system heavily against the small guy

There have been a few suggestions recently that the cost of re-exam procedures should be lowered so that the use of inter partes reviews (IPR) and covered business method (CBM) reviews, are not only affordable for the richest of players in the US…

Get unlimited access to all IAM content